ERA 2026 3 - 6 June 2026

The Effects of Semaglutide on Health-Related Quality of Life in Adults with Type 2 Diabetes and Chronic Kidney Disease: FLOW trial

Authors :

Johannes Mann^1,2; Ida Kirstine Bull Rasmussen³; Thomas P Gunnarsson³; Prachi Priyadarshini⁴;Søren Rasmussen³; Peter Rossing⁵

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Diabetes

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)